Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature

被引:14
作者
Jerez-Lienas, Alba [1 ,2 ]
Mathian, Alexis [3 ]
Aboab, Jenifer [3 ]
Crassard, Isabelle [4 ]
Hie, Miguel [3 ]
Cohen-Aubart, Fleur [3 ]
Haroche, Julien [3 ]
Wahl, Denis [5 ]
Cervera, Ricard [1 ]
Amoura, Zahir [3 ]
机构
[1] Univ Barcelona, Hosp Clin, Dept Autoimmune Dis, Barcelona 08036, Spain
[2] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Internal Med, Syst Autoimmune Dis Unit, Terrassa 08221, Spain
[3] Sorbonne Univ, Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris APHP,French Natl Referr, Inst E3M,Inserm UMRS,Serv Med Interne 2,Ctr Immun, F-75013 Paris, France
[4] Hop Lariboisiere, Dept Neurol, F-75010 Paris, France
[5] Ctr Hosp Reg Univ Nancy, Dept Vasc Med, Referral Ctr Rare Vasc Dis, F-54500 Vandoeuvre Les Nancy, France
关键词
antiphospholipid syndrome; antiphospholipid antibodies; cerebral vein thrombosis; intracranial sinus thrombosis; VENOUS SINUS THROMBOSIS; FACTOR-V-LEIDEN; INTERNATIONAL CONSENSUS STATEMENT; NONCRITERIA APS MANIFESTATIONS; PROTEIN-S DEFICIENCY; RISK-FACTORS; CLASSIFICATION CRITERIA; LUPUS ANTICOAGULANT; ANTICARDIOLIPIN ANTIBODIES; PULMONARY-EMBOLISM;
D O I
10.3390/brainsci11121641
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
(1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies. Cerebral vein thrombosis (CVT) is a rare form of cerebrovascular accident and an uncommon APS manifestation; the information in the literature about this feature consists of case reports and small case series. Our purpose is to describe the particular characteristics of CVT when occurs as part of the APS and compare our series with the patients published in the literature. (2) Methods: We conducted a retrospective observational study collecting data from medical records in three referral centers for APS and CVT, and a systematic review of the literature for CVT cases in APS patients. (3) Results: Twenty-seven APS patients with CVT were identified in our medical records, the majority of them diagnosed as primary APS and with the CVT being the first manifestation of the disease; additional risk factors for thrombosis were identified. The review of the literature yielded 86 cases, with similar characteristics as those of our retrospective series. (4) Conclusions: To our knowledge, our study is the largest CVT series in APS patients published to date, providing a unique point of view in this rare thrombotic manifestation.
引用
收藏
页数:24
相关论文
共 50 条
  • [21] Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients
    Ma, Jingran
    Song, Hongmei
    Wei, Min
    He, Yanyan
    CLINICAL RHEUMATOLOGY, 2018, 37 (05) : 1295 - 1303
  • [22] Antiphospholipid syndrome as a cause of portal vein thrombosis. Two cases.
    Bouaniche, M
    Guedon, C
    Borg, JY
    Zalar, A
    Ducrotte, P
    Lerebours, E
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1996, 20 (10): : 897 - 900
  • [23] Antiphospholipid antibodies in patients with upper-extremity deep vein thrombosis
    Nikolova-Vlahova, Milena K.
    Nikolov, Krasimir V.
    Baleva, Marta P.
    Savov, Alexey S.
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 40 (03) : 307 - 310
  • [24] Portal vein thrombosis associated with antiphospholipid syndrome
    Hirohata, Y
    Murata, A
    Abe, S
    Otsuki, M
    JOURNAL OF GASTROENTEROLOGY, 2001, 36 (08) : 574 - 578
  • [25] Portal vein thrombosis associated with antiphospholipid syndrome
    Yoshihide Hirohata
    Akitoshi Murata
    Shintaro Abe
    Makoto Otsuki
    Journal of Gastroenterology, 2001, 36 : 574 - 578
  • [26] A primary antiphospholipid syndrome presented with portal vein thrombosis.
    Cepillo, IM
    Gómez, MR
    Lacomba, DL
    Santamaría, LG
    Reina, AG
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1999, 91 (09) : 650 - 652
  • [27] Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature
    Tenti, Sara
    Cheleschi, Sara
    Guidelli, Giacomo Maria
    Galeazzi, Mauro
    Fioravanti, Antonella
    AUTOIMMUNITY REVIEWS, 2016, 15 (03) : 226 - 235
  • [28] Thrombolytic Therapy for Cerebral Vein Thrombosis in Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
    Hajialilo, Mehrzad
    Noshad, Hamid
    Mohammadian, Reza
    Khabbazi, Ali Reza
    Daghighi, Mohammad Hossein
    Saleh, Parviz
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2012, 37 (01) : 58 - 61
  • [29] Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the Literature
    Andreoli, Laura
    Chighizola, Cecilia B.
    Banzato, Alessandra
    Pons-Estel, Guillermo J.
    de Jesus, Guilherme Ramire
    Erkan, Doruk
    ARTHRITIS CARE & RESEARCH, 2013, 65 (11) : 1869 - 1873
  • [30] Antiphospholipid syndrome - clinical manifestation, diagnostics and literature review
    Gerkowicz, Agnieszka
    Chodorowska, Grazyna
    Michalak-Stoma, Anna
    Juszkiewicz-Borowiec, Maria
    Krasowska, Dorota
    Niewiedziol, Marta
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2010, 27 (01): : 69 - 75